SCHEMBL3222794

SCHEMBL3222794

CCOC(=O)c1[nH]c(C)c(C(=O)c2cccc(Cl)c2)c1C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.64
ALDH1A1 P00352 3/20 0.64
HPGD P15428 3/20 0.64
LMNA P02545 5/20 0.62
GAA P10253 1/20 0.62
HTT P42858 2/20 0.61
KMT2A Q03164 4/20 0.59
MEN1 O00255 3/20 0.59
TSHR P16473 2/20 0.59
MAPK1 P28482 2/20 0.59
NPSR1 Q6W5P4 1/20 0.59
USP2 O75604 2/20 0.58
NPC1 O15118 3/20 0.58
CASP3 P42574 1/20 0.58
SENP8 Q96LD8 1/20 0.58
SENP7 Q9BQF6 1/20 0.58
SENP6 Q9GZR1 1/20 0.58
MAPT P10636 5/20 0.57
SMN1; SMN2 Q16637 2/20 0.53
KDM4E B2RXH2 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15151635 0.87 RAB9A (0.71) RAB9AALDH1A1HPGDLMNAGAA
SCHEMBL15151500 0.86 RAB9A (0.66) RAB9AALDH1A1HPGDLMNAHTT
SCHEMBL15151410 0.86 RAB9A (0.66) RAB9AALDH1A1HPGDLMNAHTT
SCHEMBL15151541 0.86 RAB9A (0.66) RAB9AALDH1A1HPGDLMNAHTT
SCHEMBL15151516 0.85 RAB9A (0.64) RAB9AALDH1A1HPGDLMNAGAA
SCHEMBL15151643 0.85 HPGD (0.69) RAB9AALDH1A1HPGDLMNAHTT
SCHEMBL15151505 0.84 RAB9A (0.80) RAB9AALDH1A1HPGDLMNAHTT
SCHEMBL257220 0.84 RAB9A (0.79) RAB9AALDH1A1HPGDLMNAGAA
SCHEMBL15151511 0.84 RAB9A (0.63) RAB9AALDH1A1HPGDLMNAHTT
SCHEMBL15151533 0.84 RAB9A (0.63) RAB9AALDH1A1HPGDLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2808324-A1 PYRROLE COMPOUND Kabushiki Kaisha Yakult Honsha (JP) 2014-12-03 EP disclosed
US-20140343017-A1 PYRROLE COMPOUND KABUSHIKI KAISHA YAKULT HONSHA (JP) 2014-11-20 US disclosed
US-20140343017-A1 PYRROLE COMPOUND KABUSHIKI KAISHA YAKULT HONSHA (JP) 2014-11-20 US disclosed
US-20140343017-A1 PYRROLE COMPOUND KABUSHIKI KAISHA YAKULT HONSHA (JP) 2014-11-20 US disclosed
WO-2013111831-A1 PYRROLE COMPOUND 株式会社ヤクルト本社 (JP) 2013-08-01 WO disclosed
WO-2010013011-A1 P53 TUMOR SUPPRESSOR PROTEIN ACTIVATING UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) 2010-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343017-A1 PYRROLE COMPOUND TUBB3, TUBB1, TUBB RAB9A 781/4885ALDH1A1 2354/4885HPGD 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.